Clinical Trial Update: Leader - Evaluation of Endotak Reliance

View source ↗

Summary

The completed clinical trial evaluates Boston Scientific's Endotak Reliance defibrillator lead for safety and effectiveness in patients with ventricular tachyca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventricular Fibrillation
• Ventricular Tachycardia

Drugs mentioned

• Endotak Reliance

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Ventricular Tachycardia, Ventricular Fibrillation | Status: COMPLETED